131 related articles for article (PubMed ID: 21910023)
1. Survival after incidental prostate cancer diagnosis at transurethral resection of prostate: 10-year outcomes.
Ahmad S; O'Kelly F; Manecksha RP; Cullen IM; Flynn RJ; McDermott TE; Grainger R; Thornhill JA
Ir J Med Sci; 2012 Mar; 181(1):27-31. PubMed ID: 21910023
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of T1a-T1b prostate cancer].
Liu Z; Luo C; Hu S; Fan Y; Liu ZH; Yang XY; Shen Q; Liu LB; Han WK; Zhou LQ; Yu W; He Q; Zhang Q; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):812-816. PubMed ID: 27752161
[TBL] [Abstract][Full Text] [Related]
3. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
4. [Clinical relevance of incidental prostate carcinoma. A retrospective study].
Schürholz T; Schulze H; Finke W; Lange S; Senge T
Urologe A; 1996 Jul; 35(4):315-20. PubMed ID: 8928361
[TBL] [Abstract][Full Text] [Related]
5. Outcome of radical prostatectomy for incidental carcinoma of the prostate.
Melchior S; Hadaschik B; Thüroff S; Thomas C; Gillitzer R; Thüroff J
BJU Int; 2009 Jun; 103(11):1478-81. PubMed ID: 19076134
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).
Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E
BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178
[TBL] [Abstract][Full Text] [Related]
7. Early outcomes of active surveillance for localized prostate cancer.
Hardie C; Parker C; Norman A; Eeles R; Horwich A; Huddart R; Dearnaley D
BJU Int; 2005 May; 95(7):956-60. PubMed ID: 15839912
[TBL] [Abstract][Full Text] [Related]
8. Nationwide treatment patterns and survival of older patients with prostate cancer.
Vernooij RWM; van Oort I; de Reijke TM; Aben KKH
J Geriatr Oncol; 2019 Mar; 10(2):252-258. PubMed ID: 30853064
[TBL] [Abstract][Full Text] [Related]
9. Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients.
Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
Eur Urol Oncol; 2018 Aug; 1(3):231-237. PubMed ID: 31102626
[TBL] [Abstract][Full Text] [Related]
10. Oncological Outcomes After Radical Prostatectomy for High-Risk Prostate Cancer Based on New Gleason Grouping System: A Validation Study From University of Southern California With 3,755 Cases.
Djaladat H; Amini E; Xu W; Cai J; Daneshmand S; Lieskovsky G
Prostate; 2017 May; 77(7):743-748. PubMed ID: 28144967
[TBL] [Abstract][Full Text] [Related]
11. An evidence review of active surveillance in men with localized prostate cancer.
Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of incidental prostatic adenocarcinoma after suprapubic adenomectomy with or without previous prostatic biopsy].
Fernández Rosado E; Gómez Veiga F; Alvarez Castelo L; Ruibal Moldes M; Mosquera Reboredo JM; González Martin M
Arch Esp Urol; 2006; 59(1):31-42. PubMed ID: 16568691
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
14. Does laser ablation prostatectomy lead to oncological compromise?
Biers SM; Oliver HC; King AJ; Adamson AS
BJU Int; 2009 Feb; 103(4):454-7. PubMed ID: 18782304
[TBL] [Abstract][Full Text] [Related]
15. Clinical experiences of incidental prostate cancer after transurethral resection of prostate (TURP) according to initial treatment: a study of a Korean high volume center.
Lee DH; Chung DY; Lee KS; Kim IK; Rha KH; Choi YD; Chung BH; Hong SJ; Kim JH
Yonsei Med J; 2014 Jan; 55(1):78-83. PubMed ID: 24339290
[TBL] [Abstract][Full Text] [Related]
16. Triple treatment of high-risk prostate cancer. A matched cohort study with up to 19 years follow-up comparing survival outcomes after triple treatment and treatment with hormones and radiotherapy.
Gunnarsson O; Schelin S; Brudin L; Carlsson S; Damber JE
Scand J Urol; 2019; 53(2-3):102-108. PubMed ID: 30990112
[No Abstract] [Full Text] [Related]
17. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study.
Stattin P; Holmberg E; Johansson JE; Holmberg L; Adolfsson J; Hugosson J;
J Natl Cancer Inst; 2010 Jul; 102(13):950-8. PubMed ID: 20562373
[TBL] [Abstract][Full Text] [Related]
18. The significance of histological analysis following laser transurethral resection of the prostate.
Nafie S; Dormer J; Khan MA
Int Urol Nephrol; 2017 Aug; 49(8):1343-1346. PubMed ID: 28508246
[TBL] [Abstract][Full Text] [Related]
19. Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study.
Kasperzyk JL; Shappley WV; Kenfield SA; Mucci LA; Kurth T; Ma J; Stampfer MJ; Sanda MG
J Urol; 2011 Nov; 186(5):1862-7. PubMed ID: 21944095
[TBL] [Abstract][Full Text] [Related]
20. Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study.
Herden J; Schwarte A; Boedefeld EA; Weissbach L
Urol Int; 2021; 105(5-6):428-435. PubMed ID: 33517336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
